Moloney Securities Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $667K | Sell |
1,498
-300
| -17% | -$134K | 0.08% | 227 |
|
|
2025
Q1 | $872K | Buy |
1,798
+65
| +4% | +$31.5K | 0.12% | 188 |
|
|
2024
Q4 | $698K | Sell |
1,733
-149
| -8% | -$60K | 0.09% | 223 |
|
|
2024
Q3 | $875K | Sell |
1,882
-72
| -4% | -$33.5K | 0.12% | 209 |
|
|
2024
Q2 | $916K | Sell |
1,954
-11
| -0.6% | -$5.16K | 0.13% | 180 |
|
|
2024
Q1 | $821K | Sell |
1,965
-7
| -0.4% | -$2.93K | 0.12% | 196 |
|
|
2023
Q4 | $802K | Sell |
1,972
-330
| -14% | -$134K | 0.13% | 191 |
|
|
2023
Q3 | $800K | Sell |
2,302
-2,447
| -52% | -$851K | 0.14% | 178 |
|
|
2023
Q2 | $1.67M | Sell |
4,749
-249
| -5% | -$87.6K | 0.3% | 84 |
|
|
2023
Q1 | $1.57M | Sell |
4,998
-69
| -1% | -$21.7K | 0.29% | 90 |
|
|
2022
Q4 | $1.46M | Sell |
5,067
-190
| -4% | -$54.9K | 0.32% | 89 |
|
|
2022
Q3 | $1.52M | Buy |
5,257
+2
| +0% | +$579 | 0.37% | 72 |
|
|
2022
Q2 | $1.48M | Sell |
5,255
-525
| -9% | -$148K | 0.35% | 79 |
|
|
2022
Q1 | $1.51M | Sell |
5,780
-1,364
| -19% | -$356K | 0.29% | 94 |
|
|
2021
Q4 | $1.57M | Buy |
+7,144
| New | +$1.57M | 0.27% | 87 |
|